Cargando…
Comparative effectiveness of branded vs. generic versions of antihypertensive, lipid-lowering and hypoglycemic substances: a population-wide cohort study
Generic medications offer substantial potential cost savings to health systems compared to their branded counterparts. In Europe and the US, they are only approved if they are bioequivalent to the respective originator product. Nevertheless, the lack of clinical outcomes is sometimes used as the rea...
Autores principales: | Tian, Yuxi, Reichardt, Berthold, Dunkler, Daniela, Hronsky, Milan, Winkelmayer, Wolfgang C., Bucsics, Anna, Strohmaier, Susanne, Heinze, Georg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136234/ https://www.ncbi.nlm.nih.gov/pubmed/32249786 http://dx.doi.org/10.1038/s41598-020-62318-y |
Ejemplares similares
-
Regression with Highly Correlated Predictors: Variable Omission Is Not the Solution
por: Gregorich, Mariella, et al.
Publicado: (2021) -
Brand and generic medications: Are they interchangeable?
por: Al-Jazairi, Abdulrazaq S., et al.
Publicado: (2008) -
Prescription writing: Generic or brand?
por: Andrade, Chittaranjan, et al.
Publicado: (2017) -
Brand Name Versus Generic?
por: Aungaroon, Gewalin
Publicado: (2023) -
The concept of: Generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs
por: Thakkar, Karan B., et al.
Publicado: (2013)